Osseointegration of Implant Surfaces in Metabolic Syndrome and Type-2 Diabetes Mellitus

Overview

Journal J Biomed Mater Res B Appl Biomater

Specialty Biomedical Engineering

Date 2024 Feb 15

PMID 38355936

Authors

Edmara T P Bergamo

Paula G F P de Oliveira

Tiago M B Campos

Estevam A Bonfante

Nick Tovar

Daniel Boczar

Vasudev Vivekanand Nayak

Paulo G Coelho

Lukasz Witek

Affiliations

Soon will be listed here.

Abstract

This in vivo study evaluated the bone healing response around endosteal implants with varying surface topography/chemistry in a preclinical, large transitional model induced with metabolic syndrome (MS) and type-2 diabetes mellitus (T2DM). Fifteen Göttingen minipigs were randomly distributed into two groups: (i) control (normal diet, n = 5) and (ii) O/MS (cafeteria diet for obesity induction, n = 10). Following obesity induction, five minipigs from the obese/metabolic syndrome (O/MS) group were further allocated, randomly, into the third experimental group: (iii) T2DM (cafeteria diet + streptozotocin). Implants with different surface topography/chemistry: (i) dual acid-etched (DAE) and (ii) nano-hydroxyapatite coating over the DAE surface (NANO), were placed into the right ilium of the subjects and allowed to heal for 4 weeks. Histomorphometric evaluation of bone-to-implant contact (%BIC) and bone area fraction occupancy (%BAFO) within implant threads were performed using histomicrographs. Implants with NANO surface presented significantly higher %BIC (~26%) and %BAFO (~35%) relative to implants with DAE surface (%BIC = ~14% and %BAFO = ~28%, p < .025). Data as a function of systemic condition presented significantly higher %BIC (~28%) and %BAFO (~42%) in the control group compared with the metabolically compromised groups (O/MS: %BIC = 14.35% and %BAFO = 26.24%, p < .021; T2DM: %BIC = 17.91% and %BAFO = 26.12%, p < .021) with no significant difference between O/MS and T2DM (p > .05). Statistical evaluation considering both factors demonstrated significantly higher %BIC and %BAFO for the NANO surface relative to DAE implant, independent of systemic condition (p < .05). The gain increase of %BIC and %BAFO for the NANO compared with DAE was more pronounced in O/MS and T2DM subjects. Osseointegration parameters were significantly reduced in metabolically compromised subjects compared with healthy subjects. Nanostructured hydroxyapatite-coated surfaces improved osseointegration relative to DAE, regardless of systemic condition.

Citing Articles

In Vitro Bacterial Growth on Titanium Surfaces Treated with Nanosized Hydroxyapatite.

Holmstrom M, Esko S, Danielsson K, Kjellin P J Funct Biomater. 2025; 16(2).

PMID: 39997600 PMC: 11856866. DOI: 10.3390/jfb16020066.

Biomimetic Tissue Engineering Strategies for Craniofacial Applications.

Balderrama I, Schafer S, El Shatanofy M, Bergamo E, Mirsky N, Nayak V Biomimetics (Basel). 2024; 9(10).

PMID: 39451842 PMC: 11506466. DOI: 10.3390/biomimetics9100636.

References

Swindle M, Smith A, Hepburn B . Swine as models in experimental surgery. J Invest Surg. 1988; 1(1):65-79. DOI: 10.3109/08941938809141077. View

Achemlal L, Tellal S, Rkiouak F, Nouijai A, Bezza A, Derouiche E . Bone metabolism in male patients with type 2 diabetes. Clin Rheumatol. 2005; 24(5):493-6. DOI: 10.1007/s10067-004-1070-9. View

Vasak C, Busenlechner D, Schwarze U, Leitner H, Guzon F, Hefti T . Early bone apposition to hydrophilic and hydrophobic titanium implant surfaces: a histologic and histomorphometric study in minipigs. Clin Oral Implants Res. 2013; 25(12):1378-85. DOI: 10.1111/clr.12277. View

Coelho P, Pippenger B, Tovar N, Koopmans S, Plana N, Graves D . Effect of Obesity or Metabolic Syndrome and Diabetes on Osseointegration of Dental Implants in a Miniature Swine Model: A Pilot Study. J Oral Maxillofac Surg. 2018; 76(8):1677-1687. PMC: 6064394. DOI: 10.1016/j.joms.2018.02.021. View

Miyata T, Notoya K, Yoshida K, Horie K, Maeda K, Kurokawa K . Advanced glycation end products enhance osteoclast-induced bone resorption in cultured mouse unfractionated bone cells and in rats implanted subcutaneously with devitalized bone particles. J Am Soc Nephrol. 1997; 8(2):260-70. DOI: 10.1681/ASN.V82260. View

. Diabetes and periodontal diseases. Committee on Research, Science and Therapy. American Academy of Periodontology. J Periodontol. 2000; 71(4):664-78. DOI: 10.1902/jop.2000.71.4.664. View

Coelho P, Teixeira H, Marin C, Witek L, Tovar N, Janal M . The in vivo effect of P-15 coating on early osseointegration. J Biomed Mater Res B Appl Biomater. 2013; 102(3):430-40. DOI: 10.1002/jbm.b.33020. View

Muschler G, Raut V, Patterson T, Wenke J, Hollinger J . The design and use of animal models for translational research in bone tissue engineering and regenerative medicine. Tissue Eng Part B Rev. 2009; 16(1):123-45. DOI: 10.1089/ten.TEB.2009.0658. View

Jiang H, Ma X, Zhou W, Dong K, Rausch-Fan X, Liu S . The Effects of Hierarchical Micro/Nano-Structured Titanium Surface on Osteoblast Proliferation and Differentiation Under Diabetic Conditions. Implant Dent. 2017; 26(2):263-269. DOI: 10.1097/ID.0000000000000576. View

10.

Bergamo E, de Oliveira P, Jimbo R, Neiva R, Tovar N, Witek L . Synergistic Effects of Implant Macrogeometry and Surface Physicochemical Modifications on Osseointegration: An In Vivo Experimental Study in Sheep. J Long Term Eff Med Implants. 2020; 29(4):295-302. DOI: 10.1615/JLongTermEffMedImplants.2020034194. View

11.

Bonfante E, Jimbo R, Witek L, Tovar N, Neiva R, Torroni A . Biomaterial and biomechanical considerations to prevent risks in implant therapy. Periodontol 2000. 2019; 81(1):139-151. DOI: 10.1111/prd.12288. View

12.

Walsh J, Vilaca T . Obesity, Type 2 Diabetes and Bone in Adults. Calcif Tissue Int. 2017; 100(5):528-535. PMC: 5394147. DOI: 10.1007/s00223-016-0229-0. View

13.

Shibli J, Mangano C, Mangano F, Rodrigues J, Cassoni A, Bechara K . Bone-to-implant contact around immediately loaded direct laser metal-forming transitional implants in human posterior maxilla. J Periodontol. 2012; 84(6):732-7. DOI: 10.1902/jop.2012.120126. View

14.

Ajami E, Bell S, Liddell R, Davies J . Early bone anchorage to micro- and nano-topographically complex implant surfaces in hyperglycemia. Acta Biomater. 2016; 39:169-179. DOI: 10.1016/j.actbio.2016.05.017. View

15.

Koopmans S, Mroz Z, Dekker R, Corbijn H, Ackermans M, Sauerwein H . Association of insulin resistance with hyperglycemia in streptozotocin-diabetic pigs: effects of metformin at isoenergetic feeding in a type 2-like diabetic pig model. Metabolism. 2006; 55(7):960-71. DOI: 10.1016/j.metabol.2006.03.004. View

16.

Ibanez J, Jalbout Z . Immediate loading of osseotite implants: two-year results. Implant Dent. 2002; 11(2):128-36. DOI: 10.1097/00008505-200204000-00013. View

17.

Ravussin E, Smith S . Increased fat intake, impaired fat oxidation, and failure of fat cell proliferation result in ectopic fat storage, insulin resistance, and type 2 diabetes mellitus. Ann N Y Acad Sci. 2002; 967:363-78. DOI: 10.1111/j.1749-6632.2002.tb04292.x. View

18.

Branemark P, Hansson B, Adell R, BREINE U, Lindstrom J, HALLEN O . Osseointegrated implants in the treatment of the edentulous jaw. Experience from a 10-year period. Scand J Plast Reconstr Surg Suppl. 1977; 16:1-132. View

19.

Coelho P, Marin C, Granato R, Giro G, Suzuki M, Bonfante E . Biomechanical and histologic evaluation of non-washed resorbable blasting media and alumina-blasted/acid-etched surfaces. Clin Oral Implants Res. 2011; 23(1):132-5. DOI: 10.1111/j.1600-0501.2010.02147.x. View

20.

Kang B, Sul Y, Oh S, Lee H, Albrektsson T . XPS, AES and SEM analysis of recent dental implants. Acta Biomater. 2009; 5(6):2222-9. DOI: 10.1016/j.actbio.2009.01.049. View